Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 20, 2006. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding insider trading activity rather than a financial performance report.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a specific transaction by Mrs. J Younger:
- Option Exercise: On June 20, 2006, Mrs. Younger exercised options over 46,700 Ordinary shares granted on February 25, 2000, under the Glaxo Wellcome 1999 Share Option Plan at a price of GBP 14.60 per share.
- Share Sale: On the same date, 46,700 shares were sold at an average price of GBP 14.77.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the PDMR transaction.
Investor Verification Checklist
- Verify the total number of shares held by Mrs. J Younger post-transaction.
- Confirm the current status of the Glaxo Wellcome 1999 Share Option Plan.
- Review the company's most recent Form 20-F for comprehensive financial performance data, as this Form 6-K contains no financial metrics.